Cysteine

Cysteine

SCHEMBL15417993

NC(CS)C(=O)O.NCCN

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Cysteine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.84
SLC7A11 Q9UPY5 1/20 0.84
GSR P00390 2/20 0.50
CPB2 Q96IY4 2/20 0.46
ENPEP Q07075 6/20 0.46
GRIK1 P39086 2/20 0.42
SLC1A1 P43005 2/20 0.42
GRIK2 Q13002 2/20 0.42
GRM1 Q13255 2/20 0.42
GRM2 Q14416 2/20 0.42
SLC7A5 Q01650 1/20 0.42
GRM8 O00222 1/20 0.42
GRM6 O15303 1/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
CYP1A2 P05177 1/20 0.42
GRM5 P41594 1/20 0.42
GRIA1 P42261 1/20 0.42
GRIA2 P42262 1/20 0.42
GRIA3 P42263 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteine SCHEMBL15418989 1.00 PTGS1 (0.84) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL5664971 0.92 PTGS1 (0.80) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL5664976 0.92 PTGS1 (0.80) PTGS1SLC7A11GSRCPB2ENPEP
Cysteine SCHEMBL7898895 0.92 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1
Cysteine SCHEMBL5705430 0.92 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1
Cysteine SCHEMBL339562 0.92 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1
Cysteine SCHEMBL4289403 0.92
Cysteine SCHEMBL21110883 0.92 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1
Cysteine SCHEMBL95110 0.92
Cysteine SCHEMBL1868335 0.92 PTGS1 (1.00) PTGS1SLC7A11GSRENPEPGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2687539-B1 ANNEXIN V VARIANT, AND PREPARATION AND USE THEREOF TARGETPHARMA LABORATORIES (CHANGZHOU) CO LTD (CN) 2017-05-31 EP disclosed
US-8975380-B2 Annexin V variant and its preparation and application TARGETPHARMA LABORATORIES (CHANGZHOU) CO., LTD. (CN) 2015-03-10 US disclosed
US-20140127736-A1 ANNEXIN V VARIANT AND ITS PREPARATION AND APPLICATION TARGETPHARMA LABORATORIES (CHANGZHOU) CO., LTD. (CN) 2014-05-08 US disclosed
EP-2687539-A1 ANNEXIN V VARIANT, AND PREPARATION AND USE THEREOF Targetpharma Laboratories (Changzhou) Co., Ltd (CN) 2014-01-22 EP disclosed
CN-103041411-A 99Tcm-Cys-AnnexinV labeled compound with phosphatidylserine as target spot and labeling process and application thereof NANJING FIRST HOSPITAL 2013-04-17 CN disclosed